1 result for Category equals TREATMENT FOR: MENINGOCOCCAL MENINGITIS PROPHYLAXIS
Property
Value
Drug Name:
Meningococcal group B vaccine
Description:
FDA: Indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age.
Substance
